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Summary
Over the past decade, there has been an exponential increase in both the number and 
complexity of various anti-tumor therapies and drugs. These developments, in turn, 
have necessitated the development of a three-dimensional tumor tissue model that 
could adequately replicate the in vivo tumor environment. While various different 
models have been suggested, the vast majority of them rely on the use of natural 
biomaterials, such as type I collagen and Matrigel, to provide an environment that can 
mimic cell-ECM interactions. However, weaknesses such as high cost and mechanical 
inflexibility, remain large stumbling blocks. Using hydrogels formed out of both PEG-
based triblock co-polymers (Poly(MTC-VitE)1.25-PEG10k-Poly(MTC-VitE1.25), Poly(MTC-
VitE)2.5-PEG10k-Poly(MTC-VitE)2.5 and Poly(MTC-OBn)8.5 -PEG8k-Poly(MTC-OBn)8.5) 
and type I collagen, a number of three-dimensional (3D) matrices were prepared for 
tumor spheroid growth. The 3D matrices were characterized for hydrogel clarity (using 
visual observations and imaging), tumor spheroid growth (using measurements 
obtained via light microscopy), permeability (using confocal imaging of doxorubicin 
penetration) and rheological stiffness (using rheometry data), for their potential use as 
three-dimensional tumor models. What we found was that while certain types of our 
composite hydrogels showed lower levels of overall spheroid growth when compared 
with the control, one polymer (Poly(MTC-VitE)1.25-PEG10k-Poly(MTC-VitE1.25)) showed
almost identical levels of spheroid growth to those found in the collagen control, while 
possessing a high flexibility in terms of mechanical attributes, such as stiffness. 
However, certain aspects, such as anti-cancer drug permeability, remain key issues that 
must be examined more thoroughly in further studies.
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1.   Introduction
1.1   Tumor research in the modern world
Cancer  is  one  of  the  most  important  medical  challenges  currently  facing  modern
mankind. Cancers are a large group of diseases that are mainly characterized by the
mutation of normal cells into invasive, highly replicative tumorigenic cells. Via a process
called  metastasis,  these  cancerous  cells  can  then  spread  to  other  organs,  causing
extensive systemic damage to the human body, which typically culminates in the death
of the patient. According to the World Health Organization, cancerous diseases were
responsible  for  approximately  8.2  million  deaths  in  2012,  the  highest  of  any  non-
transmissible disease, and the number of new cases is expected to rise by over 70%, to
22 million, over the course of the next two decades. Furthermore, the economic costs of
various tumorigenic diseases are staggering, as seen from the fact that only the direct
medical costs of cancer treatment in the United States accounted for 88 billion dollars in
2011, while reduction in productivity due to premature cancer mortality in Europe was
estimated to account for a loss of 75 billion euros [1]. Therefore, research into potential
therapies or avenues of treatment is of absolutely vital importance from both a moral
and a fiscal standpoint.
However, due to its polygenic and multifactorial nature, complete treatment of cancer
still remains a task of almost herculean difficulty. Traditional approaches, such as chemo
and radiotherapy, have significant downsides, typically associated with systemic toxicity
and death of other rapidly dividing cells, such as hair follicle cells or hematopoietic cells
in the bone marrow. In addition, drug resistance remains an issue, even with extremely
broad target approaches such as chemotherapy.  Cellular mechanics, such as drug efflux
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through the ATP-binding cassette transporter families and up-regulation of members of
the  DNA  repair  pathways,  such  as  ERCC,  serve  as  inducers  of  chemotherapeutic
resistance  in  tumor  cells  [2].  Because  of  the  systemic  downsides  of  chemo  and
radiotherapy, more recent therapeutic approaches in cancer therapy have attempted to
solve the problem by targeting cancer-specific mutations, typically occurring in various
kinases.  However,  while  very  specific  for  tumor  cells  and  with  far  less  serious  side
effects, specific molecular targeting drugs (such as tyrosine kinase inhibitors) are still
subject  to  the  development  of  cancer  resistance,  albeit  through  different  cellular
mechanics than in the case of conventional therapies.
One  key  example  of  this  is  the  incidence  of  resistance  accompanying  the  Bcr-Abl
tyrosine kinase inhibitor,  Imatinib,  in chronic  myeloid leukemia (CML).  While initially
showing extremely  promising  results,  it  was shown that  a sizable  proportion of  the
chronic  myeloid  leukemia  patients  were  at  risk  of  primary  or  secondary  Imatinib
resistance  [3], via mutations in the target of Imatinib, BCL-ABL1  [2]. While Imatinib is
still  widely used for  the treatment  of  CML and “second generation” tyrosine kinase
inhibitors (inhibitors which are capable of both suppressing the wild type and mutant
Bcr-Abl) are now in use, resistance still remains a considerable issue with many single
target  therapies.  Because  of  the  massive  difficulties  involved  in  overcoming  drug
resistance,  and  due  to  significant  differences  between  different  tumor  variations,
creating viable and easily applicable in vitro tumor modeling systems has long been of
great interest to the medical community.
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1.2    2D tumor models
Most  tumor-related  drug  and  characterization  studies  are  performed  using  two-
dimensional cell culture models. These models typically involve cultivating a monolayer
of tumor cells on the surface of a tissue culture plate. Tests involving 2D tumor models
are relatively easy to set up and have been extensively used for both drug studies and
also to characterize the nature and behavior of a variety of different tumor cell lines.
However,  while they are simple to use, 2D culture models suffer from a number of
major drawbacks that greatly hamper their use in research and drug development.
One of the main key problems with 2D tumor cultures is their inability to induce neither
cell to cell interactions between the tumor cells, nor cell to ECM interactions that take
place between the tumor cells  and the extracellular  matrix.  These interactions have
been shown to have significant effects on a variety of different tumor cell characteristics
such as drug metabolism, protein synthesis, differentiation and cell  viability, and the
lack of these characteristics has been shown to result in increased response to anti-
cancer drugs, such as Paclitaxel [4]. Furthermore, it has been observed that in the case
of  organotypic  neoplasias,  the expression profile  of  various oncogenic  signals  differs
greatly  between  two-dimensional  tumor  cultures  and  in  vivo  tumor  tissue,  further
calling into question the ability of monolayer cultures to accurately mimic real tumor
growth and behavior [5]. 
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1.3    3D tumor models
Therefore,  to  overcome  the  limitations  associated  with  traditional  two-dimensional
tissue cultures, as well as to more accurately portray the natural cancers occurring in
patients,  a  three-dimensional  model  capable  of  replicating  the  natural  tumor
environment is necessary. This, in itself, is not a particularly novel concept, as animal
models, such as subcutaneous tumor xenografts in immunodeficient mice, have been
used in medical studies for decades to prove the efficacy of various drugs and therapies.
Unfortunately,  animal  trials  have  always  been  subject  to  a  significant  degree  of
uncertainty, due to significant biological differences between species commonly used
for  medical  trials  (such as  mice)  and humans.  For  example,  subcutaneously induced
tumors  are  rarely  useful  for  characterizing  anti-metastatic  drugs,  as  subcutaneous
xenografts very rarely metastasize in mice  [6]. In addition to the biological difficulties
involved, there are a considerable number of ethical issues involved with the use of
animals in clinical research. And while several interesting approaches are being used to
overcome many of the biological difficulties involved, such as “humanization” of mice
via  the  use  of  genetic  engineering  [7],  it  is  unlikely  that  the  ethical  controversies
surrounding the use of animals in clinical trials will truly ever disappear.  
Due to these natural drawbacks associated with animal models, various in vitro three-
dimensional  (3D)  tumor  models  have  been  proposed  over  the  course  of  the  past
decade.  Three-dimensional  in vitro  approaches can be broadly divided into variety of
categories, most of which are based on the cultivation of tumor spheroids in media or
focused  around  their  encapsulation  in  a  variety  of  ECM-mimicking  environments,
although other novel approaches, such as the use of cell printing to manufacture a 3D
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scaffold, have also been suggested as potential alternative methods for  in vitro tumor
modeling [4].
Multicellular tumor spheroids (MCTS) are aggregates of tumor cells within the 20 μm to
1  mm range  [4] and  are  naturally  formed  when  tumor  cells  are  cultivated  in  non-
adhesive or buoyant environments. Whilst growing, the spheroids will develop into a
structure  that  is  extremely  reminiscent  of  natural  tumors  appearing  in  patients.  A
gradient of rapidly expanding cells forms the outer periphery of the spheroids while cells
closer to the center form a so-called “hypoxic core”. This hypoxic core is formed out of
quiescent and necrotic cells and is characterized by low levels of oxygen, low levels of
ATP distribution and a high degree of DNA strand breaks, as can be seen in Figure 1. This
distribution of cell heterogeneity is extremely similar to that found in vascular micro-
regions of  tumors  [8] and it  has  been clearly  demonstrated that  in  MCTS display  a
significantly  higher  degree  of  drug  resistance  (typically  referred  to  as  multicellular
resistance)  than  equivalent  2D  models  [9].  Tumor  spheroids  can  also  be  scaled  up
relatively easily (via the use of non-adhesive 96-well plates or spinner flask cultivation
methods), making high throughput screening of spheroids an ever closer possibility in
the future [10].  However, several key problems remain with MCTS, most importantly
the often variable size of the cultivated spheroids and the lack of cell-ECM interactions
in standard, non-encapsulated MCTS cultures.
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Figure 1 – Characteristics of tumor spheroids.  An overview and characterization of ATP
distribution,  DNA  strand  breakage,  lactate  accumulation,  oxygen  and  glucose
distribution and histology within tumor spheroids. Figure taken from Hirschhaeuser, et
al, 2010.
In an effort to overcome this limitation, several models have been developed, where the
MCTS are placed in an ECM imitating environment. A variety of substances, both natural
and synthetic have been tested for this purpose. Amongst these, natural biomaterials
such as type I collagen and Matrigel are most commonly used, while various polyesters
and polyethylene glycol (PEG) based polymers have also been extensively studied. Type I
collagen, for example, is the most abundant type of collagen in the human body and is
the most abundant ECM protein in most tissues. Collagen gels have been shown to be
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capable of mimicking both loose and dense connective tissue, based on the collagen
concentration  [11]  and  liver  tumor  spheroids  cultivated  in  collagen  gels  have  been
demonstrated to show a higher degree of doxorubicin resistance than standard, non-
encapsulated MCTS [12]. Similar results have been demonstrated in hydrogels prepared
from Matrigel,  a mixture composed of a large variety of different ECM proteins and
growth  factors,  produced  from  Engleberth-Holm-Swarm  (EHS)  mouse  sarcoma  cells.
Matrigel has been widely used for subcutaneous tumor inoculation in mice and Matrigel
hydrogels have been widely used to study the effect of 3D matrix factors on cellular
processes such as the development of apoptotic resistance [13] and metastasis induced
morphological and gene expression changes [14]. 
Studies associated with synthetic polymers have been less successful, mainly due to the
lack of bioactivity shown by man-made materials,  in comparison to naturally derived
biomaterials, such as type I collagen. Nevertheless, materials such as porous polyester
scaffolds have been shown to possess  in  vivo  mimetic  angiogenic  signaling  [15]  and
tumor  constructs  cultivated  in  these  models  do  show  levels  of  hypoxia  clearly
resembling that of normal in vivo tumors found in patients  [16]. However, due to the
lack  of  natural  bioactivity  and  the  biological  microenvironment  (when compared  to
naturally  derived  three-dimensional  models),  tumor  cell  behavior  in  these  synthetic
models  is  extremely  variable,  greatly  complicating  their  use  as  cancer  models.  It  is
therefore not an exaggeration to say that the replication of suitable natural biochemical
signals,  material  surface  properties,  and  material  structure,  remain  the  greatest
challenges for the use of synthetic polymers for 3D tumor modeling.
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More specifically, polyethylene glycol (PEG) based polymers have been used to some
success as replacements for more natural biomaterials. Due to their high water content
and mechanical  properties,  hydrated PEG gels  closely resemble hydrogels assembled
from naturally derived biomaterials,  such as Matrigel.  In addition, PEG polymers can
serve  as  a  “neutral  template”  of  sorts,  due  to  the  possibility  of  adding  novel
biofunctional groups to the polymer, allowing for the manifestation of specific desired
cell-environment  interactions.  So  far,  this  approach  has  been  used  to  graft  various
growth factors, such as bone-morphogenic protein-2  [17] and VEGF [18], as well as to
induce basic cell attachment via the grafting of fibronectin-derived RGDS peptide onto
the surface of the polymer [19]. 
Both natural  and synthetic  matrices provide their  own specific  suit  of  strengths and
weaknesses,  which  are  covered  in  more  detail  in  Table  1.  The  greatest  strength  of
naturally  derived biomaterials is,  as mentioned earlier,  their  natural biochemical and
environmental  properties.  This  makes  them  exceptionally  suited  for  in  vitro tumor
modeling, as the natural milieu of tumor cells can be simulated far more easily and far
more accurately than in synthetic models.  While synthetic approaches,  such as PEG-
derived polymers,  hold a significant degree of potential in terms of inducing specific
cell-environment  interactions.  However,  full  replication  of  the  large  variety  of
biochemical signaling and biophysical properties found in in vivo tissues, still remains a
distant  dream  for  synthetic  biomaterials.  On  the  other  hand,  naturally  derived
biomaterials  do  possess  significant  downsides  in  certain  key  areas  needed  for  3D
modeling. One of the key problems, associated with both collagen and Matrigel, is their
relatively  inflexible  mechanical  properties.  While  slight  modifications  using  various
methods,  such  as  additional  collagen  crosslinking,  can  be  performed  to  increase
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hydrogel stiffness to a certain degree, the mechanical properties of naturally derived
hydrogels generally cannot be significantly changed. This is due to the fact that changes
to the matrix properties, via methods such as cross-linking and concentration increase,
often result in altered biochemical profiles, which greatly complicates their use in 3D
models [16], especially for examining tumors that typically grow in stiffer environments,
such as bones.  In addition, cost still remains an important limiting factor in the use of
natural  biomaterials,  as  both  purified  type  I  collagen  and  Matrigel  are  relatively
expensive, making their  use in  areas such as large-scale tumor screening,  financially
unviable. Synthetic polymers, on the other hand, are far cheaper, mechanically more
malleable and tend to act in a far more predictable manner when compared to natural
biomaterials.  
17
Table 1 – Benefits and disadvantages of synthetic and naturally derived 3-dimensional
matrices. Table derived from West and Gill, 2014.
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1.4    Aim of the project
Because of the corresponding suits of weaknesses and strengths found in both synthetic
and  natural  biomaterials,  the  aim  of  this  project  was to  determine  if  composite
hydrogels, formed from PEG-based ‘ABA’ triblock copolymers and type I collagen, could
be used for the three-dimensional modeling of liver tumors. We aimed to evaluate the
composite hydrogels suitability for 3D tumor modeling based on three specific criteria.
Firstly,  based  on  the  visual  clarity  of  the  composite  hydrogel,  a  factor  vital  for
continuous spheroid measurement and observation. Secondly, based on the rheological
stiffness of the composite hydrogels, an aspect necessary for in vitro replication of both
softer and stiffer tumor environments.  Finally, we aimed to assess the actual growth of
HepG2  spheroids  when  encapsulated  within  our  composite  hydrogels,  both  under
normal conditions and when treated with anti-cancer agents. Contrasting these results
to the control hydrogel, a 2.5% type I collagen hydrogel, it would be possible to evaluate
the suitability of the PEG-based composite hydrogels when measured against more well-
established 3D modeling approaches. 
Our target polymers for such a model were all PEG-based ‘ABA’ triblock copolymers, the
structure  of  which can be  seen  in  Figure  2.  We chose  a  PEG-based  system for  our
composite hydrogel model due to their biocompatibility in vitro and in vivo [20, 21] and
because, as mentioned earlier in Section 1.2, PEG-based hydrogel systems have been
widely  tested  for  potential  3D  tumor  modeling  due  to  their  inherently  high
biocompatibility and easily modifiable nature  [21,22]. The key strength of cross-linked
PEG-based ‘ABA’ triblock copolymers is their ease of use, as hydrogels can be formed
simply by the addition of polymer into deionized H2O and stirring. The formation of the
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cross-linked hydrogel  is catalyzed by A-A hydrophobic interactions between micelles,
which causes the formation of physical cross-linking between the ‘flower-like’ micelles
formed by the ‘ABA’ triblock copolymers [23].
The  polymers  used  for  our  composite  polymer-collagen  hydrogels  could  be  largely
divided  into  two  larger  families  based  on  their  side  chain  composition.  All  tested
polymers  either  possessed  benzyl  side  chains (Polymer  1)  or  vitamin  E  side  chains
(Polymers 2a, 2b, 2c, and 2d). Since variations of both benzyl and vitamin E containing
triblock PEG polymers have been used by our lab in the past [20, 23], we were confident
that by using these variants, we could achieve a similar rheological profile displayed by
normal collagen hydrogels. The reasoning behind the usage of either benzyl or vitamin E
as the hydrophobic block A of the ‘ABA’ copolymer, is the fact that polycarbonates are
synthesized  by  organocatalytic  ring-opening  polymerization  which  allows  for  control
over the length of the A block and its functionalities. Furthermore, as vitamin E is more
hydrophobic than benzyl, it  explains the lower number of units needed for hydrogel
formation.  All  these polymers  have shown excellent  biocompatibility  in both human
dermal  fibroblasts and  in  mice  and  were therefore  ideally  suited  for  further  cell
cultivation studies [23].
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Figure  2  –  PEG-based  polymers  for  composite  hydrogels.   Chemical  structures  of
Polymers  1,  2a,  2b,  2c and 2d used in  composite  hydrogel  models.  Three structural
elements are indicated in separate colors: blue (PEG backbone), green (aromatic benzyl
ring) and orange (Vitamin E subunit). P refers to the size of the PEG subunit while m
refers  to  the  number  of  repetitive  units  in  the  polymer  side-chains.  Degree  of
polymerization refers to the number of monomeric units in the polymer molecule.
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2.   Materials and Methods
2.1   Cell Culture
HepG2 liver cancer cell line, stored in liquid nitrogen, was used for cell culture (P<20).
Cells were cultivated in Dulbecco’s modified Eagle medium (with 4.5g glucose and L-
glutamine),  supplemented with 10% fetal bovine serum (FBS) and 1% penicillin.  Cells
were then subcultured for the duration of three days in a  37°C, 5% CO2 incubator.
2.2   Agarose Plate Preparation
To induce cell aggregation and spheroid formation, HepG2 cells were cultivated on non-
adhesive 96-well plates coated with agarose. A 1.5% agarose solution was formed by
combining 300mL of 1x phosphate buffered saline (PBS) with 4.5g of agarose (1st Base,
Singapore).  This  mixture was then microwaved until  the complete dissolution of the
agarose into the solution could be observed. 75µl of heated agarose solution was then
transferred to each well on the 96-well plates using a multi-headed pipette and allowed
to cool for 30 minutes.
2.3    Spheroid Formation
Subcultured HepG2 cells were washed with 1x PBS and treated by 0.25% trypsin-EDTA
for 5 minutes in a 37°C, 5% CO2 incubator to facilitate cell detachment. Cells were then
transferred to a 50ml falcon tube, followed by vortexing to physically break apart any
remaining  cell  aggregates.  Cell  density  in  the  resulting  cell  suspension  was  then
measured using a C-Chip© disposable hemocytometer and HepG2 cells  were seeded
onto agarose covered 96-well plates at a cell density of 2000 cells per well. The 96-well
plates were then subjected to 5 minutes of centrifugation at 1000rpm to facilitate the
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formation of cell aggregates and then incubated for 3-4 days at 37°C, 5% CO 2, until the
formation of spheroids. 
2.4   Collagen Gel Preparation
Type I collagen (rat tail, 3mg/mL solution) was obtained from Life Technologies. A 2.5%
collagen gel solution was formed using 10x PBS, 1N NaOH, and sterile distilled water, as
per the manufacturer’s instructions, which can be seen in  Figure 3.   The subsequent
2.5% collagen mixture was then stored on ice and 150µl of the solution was transferred
into each sample well. HepG2 spheroids were then transferred from agarose-covered
plates into the collagen-containing wells via pipette. Plates were then transferred to a
37°C, 5% CO2  incubator for 45 minutes to allow the gel to solidify and 100µl of growth
media (DMEM) was then added to each well and replenished daily.
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Figure  3  –  Guidelines  for  collagen  hydrogel  formation.  Gelation instructions  were
provided by the manufacturer (Life Technologies).
2.5   Composite Gel Preparation
Both vitamin E  and benzyl-based  triblock  copolymers  were  weighed  for  the  desired
concentration  and  dissolved  in  deionized  water.  The  polymer  solution  was  then
transferred  into  wells  on  a  96-well  plate  and  mixed  with  2.5% collagen  solution  to
achieve the final desired gel composition, with a total volume of 150µl per well.  For
vitamin  E  polymers  with  a  degree  of  polymerization  higher  than  1.7,  an  additional
heating step using an Eppendorf Thermomixer was performed at 60°C, 450rpm for 30
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minutes, to achieve a homogeneous polymer solution. After formation of the composite
solution, spheroids were transferred into the well via pipette and the gels were placed
in an incubator at 37°C, 5% CO2 for 45 minutes to facilitate gelation. DMEM was then
subsequently added and replenished daily.
2.6    Spheroid Measurement
Spheroid  diameters  were  observed  and  measured  daily  using  a  Leica  DMI6000  B
inverted light microscope at ten times magnification. 
2.7   Rheological Measurement
Hydrogels were formed, using methods described in Sections 2.4 and 2.5, within 2.5ml
Eppendorf tubes. The G’(Pa) of all tested hydrogels were then measured using an ARES
G2 rheometer. Measurements were conducted using an 8mm parallel plate and under
0.7% strain.
2.8   Cell Viability Assay
Any remaining DMEM was removed from both the composite and collagen gel wells and
150µl  of  collagenase IV  was  added at  1mg/ml  concentration.  The  plates  were then
returned to the 37°C, 5% CO2  incubator for three hours, after which 27µl (1/10th of the
volume present  in  each  well)  of  PrestoBlue™ reagent  was  added to  each  well  and
incubated for a subsequent 18 hours. After incubation, absorbance was measured using
a  spectrometer  at  570nm,  using  a  600nm  reading  as  a  reference  wavelength  for
normalization.
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2.9   Confocal Imaging
Collagen and composite gels were dissolved as outlined in section 2.7. Spheroids were
then  transferred  into  Lab-Tek  Chambered  Borosilicate  Coverglass  Trays  and  imaged
using a confocal microscope.
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3.   Results
3.1   Visual Measurements
Over  the  course  of  7  days,  visual  spheroid  measurement  in  a  variety  of  different
composite hydrogels showed a large variability in spheroid response and growth rates
between different gels. It became quickly obvious that composite hydrogels formed out
of Polymer 1 showed an extremely high degree of opaqueness, making visual spheroid
observations extremely difficult. However, Polymers 2a, 2b, 2c and 2d (Figure 2), formed
a clearer hydrogel, although the degree of opaqueness present still surpassed that of
the 2.5% collagen hydrogel, which was used as a control. The visual clarity of the variety
of composite hydrogels can be seen in Figure 4. In addition, Polymer 1 hydrogels were
shown to be difficult to dissolve, as both collagenase type IV and PBS were unable to
dissolve  the  composite  hydrogel.  In  comparison,  for  Polymers  2a,  2b,  2c  and  2d,
collagenase IV proved sufficient to dissolve the hydrogel for further studies.
Normal growth measurements of over the course of a week showed that the tested
vitamin E composite gels  fell  into two separate categories (Figure 5).  Lowest overall
spheroid growth was shown in composite hydrogels formed using Polymer 2d. This low
growth rate was observed at different concentrations, as a similar degree of reduced
spheroid growth was seen at both 1.6mg and 3.3 mg concentrations. The second group
of polymers, from the Polymer 2a/b/c family, showed better growth rates, closer to that
observed in 2.5% collagen gels, especially Polymer 2c. When comparing between the
growth rate of Polymers 2a, 2b and 2c, it  seems that spheroid growth in composite
hydrogels is somewhat dependent on the degree of polymerization (DP) possessed by
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the polymers, as increasing the DP from 1.2 to 1.7 (from Polymer 2a to 2c) resulted in a
noticeable  increase  in  both  spheroid  size  and  volume.   Due  to  the  high  degree  of
structural similarity between Polymer 2a/2b/2c and the Polymer 2d, the lowered growth
rate is most likely due to the increased amount of vitamin E side-chains in Polymer 2d,
changing the mechanical and micro-environmental structure of the composite hydrogel.
In addition, a high degree of variability is visible in the data. This is most likely due to the
inherent batch to batch variability between spheroid cultivation cycles,  spheroid cell
counts, size and, most importantly, spheroid cohesion - all of which can vary by quite a
fair margin from batch to batch. It is quite likely that due to lowered spheroid cohesion
in  the  spheroid  cultivation  batch,  the  transfer  process  may  have  caused  the  outer
periphery of cells shear off during the transfer process, and through that, increased the
degree of variation present in the dataset. Nevertheless, the two categories mentioned
earlier were still clearly distinguishable, even with increased variability present in the
data.
Figure 4 – Visual clarity of composite hydrogels. All composite hydrogels were formed
using 1.66% collagen concentration and images shown above were taken on Day 1.
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Figure 5 – Hydrogel encapsulated spheroid growth over seven days. Measurements of
the average spheroid diameter increase, in micrometers, over the course of seven days.
Spheroid size at Day 1 was considered to be the zero value. Error bars represent the
standard error of the provided values.
When doxorubicin (Dox)  was added to hydrogel  encapsulated HepG2 spheroids,  the
encapsulated  spheroids  showed  much  lower  levels  of  doxorubicin  response  when
compared to normal,  unencapsulated,  spheroids  (Figure  6).  Even when treated with
doxorubicin, a DP-associated increase in spheroid growth was observed between the
composite hydrogels, as an increase in the degree of polymerization of the polymer was
observed to result in higher growth and lowered doxorubicin response. Furthermore,
Polymer 2c composite hydrogels showed growth rates surpassing even that of normal
2.5%  collagen  gels.  This  trend  was  further  confirmed  when  the  doxorubicin
concentration  was  increased  by  five  times  (Figure  7),  where  a  similar  decrease  in
doxorubicin response could be observed between the 2c variant and the 2.5% collagen
hydrogel.  We then  treated  the  spheroids  using  our  in-lab  experimental  doxorubicin
carrier system, which implements boronic acid/urea based mixed micelles to load and
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carry doxorubicin. This system, formed using acid-functionalized and urea-functionalized
diblock copolymers, has shown high levels of drug loading in our in-lab tests, as well as
showing  a  pH-dependent  release  of  doxorubicin  in  vitro.   However,  tests  using
doxorubicin  loading  mixed  micelles  further  reinforced  the  data  obtained  using  free
doxorubicin, as drug resistance in the 2c composite hydrogels was still seemingly higher
than in comparative collagen hydrogels.
Figure 6 – Spheroid Growth after Doxorubicin Treatment (IC50). Measurements of the
average spheroid diameter increase, in micrometers, over the course of seven days after
doxorubicin treatment. Spheroid size at Day 1 was considered to be the zero value. Error
bars represent the standard error of the provided values.
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Figure  7  –  Spheroid  growth  rate  at  day  7  after  doxorubicin  treatment  (IC50x5).
Spheroid volume increase or decrease compared to the day 1 values. Control refers to
non-encapsulated  media  suspended  spheroids,  without  doxorubicin  treatment.  Free
spheroid  refers  to  non-encapsulated  media  suspended  spheroids,  with  doxorubicin
treatment  (at  IC50x5).  Free  Dox  (b)  refers  to  results  obtained  from  using  free
doxorubicin, while Dox/B+U Mixed Micelles (a), refers to results obtained using our in-
lab doxorubicin/boronic-urea based mixed micelle system.
3.2   Rheological Measurements 
Rheological measurements regarding the stiffness of the various hydrogels in question
have  been  summarized  in  Figure  8.  From  the  results,  we  can  see  that  Polymer  1
composite hydrogels showed a far higher G’(Pa) value at 1Hz than the 2.5% collagen
hydrogel used as a control. However, vitamin E based triblock copolymers all showed a
stiffness profile far more similar to that of the 2.5% collagen control (136 G’(Pa)).  In
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terms of individual G’(Pa) values, a stepwise increase in hydrogel stiffness was found to
correspond to an increase in the degree of polymerization within the Polymer 2a/b/c
family.   Polymer 2a composite hydrogels  were shown to be around 85 G’(Pa),  while
Polymer 2b and 2c variants showed a G’(Pa) value 145 and 214, respectively.
Figure 8 – Rheological stiffness of composite hydrogels at 1Hz. G'(Pa)  refers to the
storage modulus value at 1Hz. One 1Hz is equivalent to the Angular Frequency at 6.3
rad/s. Percentage values in the legend refer to the concentration of collagen present in
the composite hydrogels. 
Hydrogel Composition G'(Pa) at 1Hz
2.5% Collagen 137
Polymer 2d 1.66mg/1.66% 182
Polymer 2a, 1.66mg/1.66%  105
Polymer 2b, 1.66mg/1.66% 155
Polymer 2c, 1.66mg/1.66%  214
Polymer 2c 3.3mg/1.66% 490
Polymer 1, 1.25mg/1.66% 541
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Table  2 – Rheological  stiffness  of  composite  hydrogels  at  1Hz. G'(Pa)  refers  to the
storage modulus value at 1Hz. One 1Hz is equivalent to the angular frequency at 6.3
rad/s. Percentage values refer to the concentration of collagen present in the composite
hydrogels.
3.3   Confocal Imaging
Summarized  in  Figure  9,  confocal  imaging  results  of  spheroids  treated  with  free
doxorubicin and boronic-urea based doxorubicin micelles at five times the IC50 value,
showed a significant  level  of  doxorubicin  uptake (for both free doxorubicin  and the
micellar form) within the spheroids. However, while high levels of drug uptake were
seen in non-encapsulated spheroids, spheroids grown in 2.5% collagen and spheroids
obtained  from  Polymer  2b  composite  hydrogels,  visible  drug  permeability  in  the
Polymer  2c  composite  hydrogels  was  greatly  reduced  in  comparison  to  the  other
samples.  In  addition,  the  boronic-urea  based  doxorubicin  micelle  system  seemingly
showed a slightly higher degree of drug accumulation within the HepG2 spheroids when
compared  to  the  free  doxorubicin  treatment.  However,  the  degree  of  increased
brightness observed was quite slight, necessitating the use of further, more quantifiable,
studies  to  accurately  determine  the  effectiveness  of  the  Dox/B+U  micelles  when
compared to free doxorubicin. 
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Figure 9 – Confocal imaging of hydrogel encapsulated HepG2 spheroids. Distribution of
doxorubicin within the spheroids has been visualized by red coloring.  Imaging starts
from the first sign of fluorescence (Top) and subsequent images were taken after every
10 micrometers. Percentages in the naming scheme refer to the percentage of collagen
present in the composite hydrogels. All images have been brightened by 50%.
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3.4   Cell Viability Assay
A comparison cell viability assay between the Polymer 2b and 2c composite hydrogels,
and the collagen control was set up using PrestoBlue™ reagent, the results of which can
be seen in  Figure 10.  Overall  cell  viability  amongst the hydrogels  was of a relatively
similar  level,  with  Polymer  2c  composite  hydrogels  showing slightly  higher  levels  of
absorbance  and  with  the  2.5%  collagen  hydrogels  and  the  Polymer  2b  composite
hydrogels showing slightly smaller amounts of cell viability. The lowest amount of cell
viability  was,  however,  clearly  shown  by  the  standard  two-dimensional  cell  culture
model. However, while all composite gels showed a higher degree of cell viability when
compared  to  the  equivalent  2D  model,  a  further,  larger  scale  cell  viability  study  is
necessary to better establish the differences between the various hydrogels  when it
comes to cell viability.
Figure  10  –  Cell  viability  comparison  of  composite  hydrogels  under  doxorubicin
conditions.  Percentages in  the naming scheme refer  to  the percentage of  collagen
present  in  the  composite  hydrogels.  2D  cell  culture  refers  to  standard  attachment
culture  seeded  and  cultivated  at  the  equivalent  level  to  the  hydrogels  in  identical
environments (2000 cells for 5 days, 96-well plate).  
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4.   Discussion
4.1   Composite hydrogel environment
Changes in the overall hydrogel environment have been shown to possess a significant
effect on a variety of different tumor cell parameters. Most important amongst these
environmental factors is hydrogel stiffness, which has been shown to be responsible for
a variety of different tumor cell characteristics, such as invasion and metastasis [24], as
well as overall bioactivity and drug resistance [16]. 
Hydrogel  stiffness  is  also  one  of  the  major  weaknesses  associated  with  natural
biomaterials. Because of the naturally low G’Pa that collagen hydrogels exhibit, their use
as 3D models is currently only limited to tumors occurring in softer tissue (such as the
liver) and not to cancers occurring in stiffer environments (such as bone).  While the
stiffness of collagen hydrogels can be increased via chemical methods such as collagen
cross-linking,  such  approaches  have  been  shown  to  have  their  own  significant
downsides, as they result in altered matrix biochemistry, complicating further studies
[25]. 
The overall stiffness profile of our tested composite hydrogels varied significantly, due
to a variety of factors, such as concentration, degree of polymerization and feed ratio,
but most importantly due to structural differences between the polymers. The largest
and most visible difference in terms of hydrogel stiffness could be seen between the
benzyl-based composite hydrogels and the other tested hydrogels. While higher levels
hydrogel stiffness were achieved in composite gels using this polymer, we were unable
to  replicate  the  naturally  softer  G’(Pa)  values  traditionally  associated  with  collagen
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hydrogels (in  our  case,  our  2.5% collagen hydrogel  control).  This  could  be due to a
number of reasons, but one possible explanation could be due to the increased amount
of pi-stacking taking place between aromatic benzyl rings present in the side-chains of
the Polymer 1, which would increase non-covalent interactions between the rings and
result in increased hydrogel stiffness.
On the other hand, hydrogels formed using vitamin E based triblock copolymers (and its
variants),  displayed  a  stiffness  profile  far  closer  to  that  of  our  collagen  control.  In
addition, vitamin E based hydrogels still  showed a remarkable level of modularity in
terms of stiffness, as an increase in the overall G’Pa could be seen with the increase in
both the concentration and the degree of polymerization present in the polymer. More
specifically, Polymers 2a, 2b, and 2c showed the most similar results to that of the 2.5%
collagen  control.  Additionally,  changes to  the degree  of  polymerization,  allowed for
relatively  precise  manipulation  (in  the  area  of  60-70  G’Pa)  of  composite  hydrogel
stiffness.   An  increase  in  the  concentration  of  the  polymer,  however,  resulted  in  a
corresponding, larger, increase in hydrogel stiffness, up to the 500 G’Pa range. All this
indicates that when used in a composite hydrogel, the 2a/b/c family of polymers can not
only replicate the natural level of stiffness found in normal collagen hydrogels but can
also  potentially  greatly  elevate  rheological  hardness  of  the  composite  hydrogel,
suggesting that the mechanical parameters of the tested vitamin E composite hydrogels
are highly malleable and easily modifiable.
4.2   Visual observations and spheroid growth
Visual observation of spheroid diameter has often been used in 3D tumor models as a
representation of tumor growth and this has been used to assess the potential viability
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of  3D models  in  both  liver [12] and  breast  cancer  [26].  The  transparent  nature  of
naturally  derived  hydrogels  serves  as  a  great  boon  in  this,  as  observations  can  be
performed over a longer period without actually dissolving gel matrix. It is because of
this  that  the  transparency  of  our  proposed  composite  system  is  of  paramount
importance. If visible measurements cannot be performed, the potential usability of our
proposed system diminishes significantly. 
It is in this that we faced the largest problems associated with our composite hydrogel
systems. In general, the PEG-based polymers that were used all resulted in the loss of a
certain  degree  of  transparency  when  compared  with  the  collagen  control.  The
transparency of the various hydrogels can be better seen in  Figure 4. The most visibly
opaque hydrogels were formed by the Polymer 1 composite hydrogels while the vitamin
E based composite matrices showed a smaller, but still noticeable, increase in hydrogel
opaqueness. For vitamin E based hydrogels, we found that spheroid placement inside
the gel suddenly became much more vital for accurate spheroid measurement.  More
specifically, spheroids placed nearer to the bottom of the well  were far more visible
than  spheroids  placed  in  the  upper  half  of  the  hydrogel  (Figure  11).  By  specifically
transferring  the spheroids  to  the lower third  of  the hydrogel  (as  opposed to simply
transferring them into the gel without concern for their position within it),  we were
capable of increasing the quality of our visual measurements to an acceptable range.
However, even using this method, we were not capable of actually achieving good visual
clarity for spheroids cultivated in Polymer 1-based hydrogels. 
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Figure 11 – The effect of spheroid localization on visibility. Contents of hydrogel wells
have been represented in four  colors:  yellow (hydrogel),  pink (DMEM media),  white
(empty well space) and black (HepG2 spheroid). The arrow represents the approximate
position of the spheroids in regards to the bottom of the 96-well. From the two images,
one  represents  a  spheroid  with  blurred  boundaries  (a)  and  the  other  represents  a
spheroid  with  clear  boundaries  (b).  Blurriness  increases  proportionally  with  distance
from the bottom of the well. Scale bar represents the distance of 100 micrometers.
As mentioned in Section 3.1, visual diameter measurements of encapsulated spheroids
showed a high amount of variability in their growth rate. The lowest amounts of growth
were  observed  in  spheroids  encapsulated  in  Polymer  2d  composite  hydrogels.  The
amount of growth shown in these hydrogels (approximately 20µm by Day 7) was far
below that shown by the collagen control  (approximately 50µm by Day 7).  A similar
pattern  of  growth  was  also  seen  in  higher  concentration  variants  of  the  composite
hydrogel  in  question,  suggesting  that  it  was an intrinsic  property  of  the polymer in
question, rather than an effect caused by increased stiffness or concentration. Because
of the structural similarities between other members of the Polymer 2 family, this is
39
most likely due to increased amount of hydrophobicity caused by the higher number of
hydrophobic vitamin E groups attached to the PEG backbone. Another potential reason
could be hydrogel  porosity,  as the increased number of side-chains may lead to the
formation  of  smaller  pores  in  the  Polymer  2d  composite  hydrogel  itself,  thereby
negatively affecting spheroid growth. 
Polymer 2a/b/c family hydrogels, however, showed higher rates of growth, more closely
mimicking spheroids grown in the 2.5% collagen hydrogel. In particular, the Polymer 2c
showed extremely similar growth rates (approximately 45 µm by Day 7) to the control.
In general, variations in the degree of polymerization resulted in a significant difference
in spheroid size, as can be seen from the lower spheroid growth rates shown by the
Polymer 2a and 2b composite hydrogels. All in all, using the 2c variant of the vitamin E
polymer,  we  were  capable  of  replicating  results  shown  by  hydrogels  formed  from
natural biomaterials, indicating that our composite polymer-collagen hydrogel can be
used as a substitute for pure collagen hydrogels, without causing a negative impact on
the growth rate of liver tumor cells.
4.3   Response to anti-cancer treatment
To  further  examine  the  effects  of  the  composite  hydrogel  on  the  encapsulated
spheroids, we conducted a series of growth experiments using doxorubicin. Doxorubicin
is a chemotherapeutic antitumor agent that is in wide-scale medical use for treating a
variety  of  different  carcinomas  and  sarcomas  in  cancer  patients.  In  research,
doxorubicin is used mainly due to its ease of use and natural photosensitivity. It is often
among  the  first  drugs  to  be  tested  in  novel  tumor  models  and  has  been  in  use  in
patients for over three decades [27]
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An initial  doxorubicin  study,  conducted  over  the  course  of  seven  days  (doxorubicin
added at the IC50 value), showed surprising results. Out of all the hydrogels tested, the
highest  doxorubicin  resistance  was  shown  by  spheroids  cultivated  in  Polymer  2c
hydrogels, even surpassing the results displayed by the 2.5% collagen control. Even at a
lower polymer concentration, Polymer 2c composite hydrogels still showed equivalent
results to the collagen baseline and displayed equivalent amounts of spheroid growth.
As  shown by  previous  studies [12,  16],  non-encapsulated  spheroids  display  a  much
lower degree of doxorubicin resistance when compared to spheroids encapsulated in
hydrogels, something which we also observed from our data, where non-encapsulated
spheroids showed a markedly lower degree of doxorubicin resistance in comparison to
our tested hydrogels. While Polymer 2a composite hydrogels displayed a lower growth
rate  compared to the Polymer 2c  hydrogels,  the level  of  growth displayed was still
equivalent to the 2.5% collagen hydrogel control, achieving similar results.
A more limited secondary study with increased doxorubicin amounts (IC50x5) was also
carried  out.  Experimental  results  obtained  from  this  secondary  study  further
corroborated the original data (Figure 7), as even at far higher concentrations, Polymer
2c hydrogels consistently showed a lowered response to doxorubicin in comparison to
both the collagen hydrogels  and  non-encapsulated spheroids.  This  data  was further
reinforced by  replicate  studies  done using  our  experimental  Dox/B+U mixed micelle
system, in which Polymer 2c composite hydrogels  yet again showed similar levels  of
increased drug resistance in comparison to the 2.5% collagen hydrogel and the non-
encapsulated  spheroid  control.  A  similar  result  could  be  seen from the  PrestoBlue®
testing, where Polymer 2c composite hydrogels showed slightly higher levels of overall
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cell viability under doxorubicin (IC50) conditions when compared to either the collagen
control or the Polymer 2b composite hydrogel, as can be seen from Figure 10.
From our perspective, there were two potential explanations for this sudden, and quite
dramatic,  increase  in  doxorubicin  resistance.  Firstly,  this  could  be  a  natural  cellular
response  triggered  by  the  altered  cellular  environment  present  in  the  composite
hydrogels. While the gross mechanical strength of the Polymer 2c composite hydrogels
was  quite  similar  to  those  displayed  by  the  2.5%  collagen  control  (Figure  8),  even
microenvironmental  changes  in  synthetic  polymer  networks  can  result  in  significant
changes  in  cell  organization  and  dissemination [28].  Secondly,  and  more  likely,  the
reason for this increased doxorubicin resistance was due to lowered drug permeability
through the hydrogel, which would result in lower levels of doxorubicin reaching the
cells. To see whether or not this was the case, we conducted confocal microscopy study,
taking advantage of the natural photosensitivity of doxorubicin to display the amount
doxorubicin reaching the HepG2 cells, which would allow us to determine whether or
not drug permeability was causing the lowered anti-cancer response.
Confocal imaging results can be seen in  Figure 9 and show a generally high uptake of
doxorubicin  in  most  of  the  spheroids  cultivated  in  composite  hydrogels.  The  only
exception for this is the Polymer 2c composite hydrogel, where lower overall uptake for
both the free and micellar boronic-urea form of the doxorubicin, was observed. This lack
of drug uptake, at least to the same degree, was not observed in Polymer 2b-based
composite hydrogels, suggesting that the increase in the degree of polymerization of the
polymer was at least partially responsible for lowered doxorubicin penetration through
the composite hydrogel.  This  aspect is most likely also responsible for the increased
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doxorubicin  resistance  observed  in  visual  testing.  The  results  obtained  are  rather
troubling, as they seem to suggest that the polymers within composite hydrogels may
actively hinder the entry of various anti-cancer drugs,  at  the very least the entry of
doxorubicin, potentially calling into question their use as a relevant platform for anti-
cancer  drug  testing.  Further  studies  using  anti-tumor  agents  with  varying  chemical
properties and structures are needed to look into this aspect in depth, as doxorubicin
may, in actuality, be binding to the polymer portion of the composite hydrogel. This may
be  happening  through  several  potential  mechanisms.  For  example,  there  might  be
hydrophobic  interactions  between the vitamin E  group and the hydrophobic  groups
present  on  doxorubicin.  Another  potential  cause for  this  may be hydrogen bonding
between the PEG group and the peripheral -OH and O groups present on doxorubicin.
However, while the Polymer 2c composite hydrogel is not, in actuality, increasing the
rates of doxorubicin resistance, the high cell growth observed in these hydrogel models
does still indicate that an equal rate of spheroid growth to that of the 2.5% collagen
control can be achieved in Polymer 2c composite hydrogels, despite the lowered levels
of doxorubicin permeability.
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5.   Conclusion
Five polyethylene glycol-based polymers were synthesized and tested for their potential
suitability  for  a  composite  polymer-collagen  hydrogel  model  for  three-dimensional
tumor modeling. A variety of key factors vital for 3D tumor models, such as hydrogel
stiffness, visibility, and cell growth were observed, and the results were compared to a
2.5% collagen hydrogel, used as a control.
Firstly, the transparency of the composite hydrogels was assessed. As transparency of
hydrogels is vital for observing spheroid growth and response in real time, a sufficient
degree of transparency in tested composite hydrogels was extremely important  [29].
Overall, the transparency of composite hydrogels was lower than that of the collagen
control. Polymer 1 showed exceptionally low visibility, to the point where in the vast
majority  of  the  cases  the  spheroids  were  completely  unidentifiable  using  a  light
microscope. For Polymers 2a, 2b, 2c, and 2d, visibility was lower when compared to the
collagen  control,  but  still  sufficient  for  proper  measurement  and  observation.  In
addition, clarity in Polymers 2a, 2b, 2c, and 2d, could be further increased via the careful
placement of the spheroid in the lower third of the hydrogel.  
Secondly, the stiffness of composite hydrogels was measured using a rheometer. Results
showed that even at the lowest possible polymer concentrations, Polymer 1 showed the
highest level of mechanical stiffness, approximately five times that of the 2.5% collagen
hydrogel while Polymer 2b composite hydrogel showed a stiffness profile closest to that
of the collagen control. In general, Polymers 2a, 2b, 2c, and 2d were found to have a
relatively similar stiffness range to that of the 2.5% collagen hydrogel while displaying a
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minor  stepwise  increase  in  G'(Pa)  corresponding  to  the  increasing  degree  of
polymerization. In addition, Polymer 2c stiffness was shown to be responsive to polymer
concentration increase, which greatly increased the G'(Pa) of the composite hydrogel,
showing a high degree of mechanical malleability.  At this point, due to the inherent
opaqueness of the hydrogel and its extremely high stiffness, we decided to set aside
Polymer 1 composite hydrogels and focus our attention on Polymer 2-family composite
hydrogels for further testing.
When measuring tumor spheroid size, Polymer 2c showed the closest growth rates to
that of the control, while both Polymer 2a and 2b composite hydrogels showed overall
lower spheroid growth.  Lowest amount of  cell  growth was displayed by Polymer 2d
composite  hydrogels,  where  extremely  low  rates  of  growth  (~20μm)  were  seen  at
comparable polymer/collagen concentrations to other tested hydrogels. Similar results
were also seen when the polymer concentration was doubled. As with Polymer 1, we set
aside Polymer 2d for our further studies, as the composite hydrogel environment was
shown  to  be  unsuitable  tumor  cell  cultivation.  Growth  observations  under  normal
conditions were then followed up by the examining spheroid response to anti-cancer
drugs, namely doxorubicin. 
Doxorubicin testing showed that Polymer 2c composite hydrogels showed unusually low
levels of doxorubicin response, both at lower and higher drug concentrations. Other
composite hydrogels  (Polymers 2a and 2b) showed approximately equivalent growth
rates to the control. Similar results, showing higher levels of doxorubicin resistance in
Polymer 2c composite hydrogels, were also obtained from cell viability assays. Further
studies using confocal  microscopy showed that the Polymer 2c composite hydrogels
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suffer  from  lowered  permeability,  reducing  the  levels  of  doxorubicin  reaching  the
HepG2  spheroids.  This  suggests  that  a  relatively  minor  change  in  the  degree  of
polymerization can have significant effects on drug penetration in composite hydrogels. 
All  in  all,  several  considerable  difficulties  remain  with  the  complete  application  of
composite  hydrogels  as  a  three-dimensional  tumor  model.  Even  though  we  were
capable of generating a number of composite hydrogels (members of the 2a/b/c family)
that showed a relatively high degree of cell growth, while possessing stiffness profile
similar to that of collagen hydrogels, and one polymer (Polymer 2c) in particular was
capable of showing almost identical levels of spheroid growth to those found in our
collagen  control,  problems such  as  low drug  permeability,  reduced  cell  growth  and
visibility still remain key issues to overcome in all our tested composite hydrogels. Most
importantly, the largest issue currently limiting the usage of composite hydrogels as a
tumor model is their relative unwieldiness. This is due to the fact that one of the key
issues restricting the usage of biologically derived hydrogels, in addition to their price, is
the  relatively  high  amount  of  expertise  needed  to  conduct  various  assays  using
materials such as type I collagen and Matrigel. In this aspect, a lot of work is needed to
further refine our composite hydrogels from a usability standpoint, as several additional
steps (such as heating) were added to facilitate the proper formation of our composite
hydrogels. 
Nevertheless, if current difficulties could be overcome, potential still remains for the use
of composite hydrogels 3D tumor modeling, as we were capable of producing a hydrogel
that closely mimicked the standard collagen hydrogel in terms of rheological stiffness
and cell growth. Since the characteristics of composite hydrogels can be greatly changed
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via the use of various side-chains, degrees of polymerization and both the polymer and
collagen concentrations, it is quite likely that by varying these parameters, it is possible
to overcome the problems currently associated with the tested composite hydrogels.
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6.   Future work
From our studies, we have identified Polymer 2c as the most suitable target for use in a
composite  three-dimensional  hydrogel  model.  Further  optimization  studies  involving
larger variety of polymer and collagen concentrations, different tumor cell lines (such as
MDA-MB-231 breast  cancer cells),  use of  different anti-cancer  drugs  and a more in-
depth study of the mechanical properties and the overall  structure of the composite
hydrogels would allow for a more thorough characterization and optimization of our
proposed tumor model. Due to their quite similar structure, further studies using the
other members of Polymer 2a/b/c family may also provide further insight into Polymer
2c, especially in terms of structural factors such as permeability (as that has been shown
to differ  between the polymers  in  question)  and porosity.   Spheroid  growth studies
could be expanded on as well, using methods such as fluorescence activated cell sorting
(FACS)  to  count  the  specific  number  of  cells  in  each  spheroid  before  and  after
treatment, along with further replicate studies involving normal, non-treated, HepG2
spheroid growth in composite hydrogels to reduce the variation present in the current
dataset.
When  discussing  specific  permeability  studies,  further  research  using  more  or  less
hydrophobic and reactive anti-cancer drugs could be used to determine whether or not
the reduced doxorubicin permeability is due to binding to the polymer present in the
composite hydrogels.  Studies including more hydrophobic anti-tumor agents (such as
Paclitaxel) as well  as more non-reactive agents (a non-hydrophobic control molecule
with a marker), could potentially allow for a far better understanding of the topic. 
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In addition, up-regulation of various growth and pro-angiogenic factors, such as HIFα
and VEGF-A has also been shown to be an important key difference between 2D and 3D
tumor models [30]. Quantitative reverse transcription polymerase chain reaction (qRT-
PCR) studies could potentially shed light on whether or not polymer-collagen composite
hydrogels show an equivalent level of increased gene expression when compared to
fully collagen-based hydrogels. Efforts towards perfecting the usability of the composite
hydrogel  model should also be increased.  This  is  due to the fact  that currently,  the
composite  hydrogel  model  is  relatively  unwieldy  and  requires  a  high  amount  of
experience and practice for its normal use. This is mainly caused by the viscous nature of
the dissolved 2c polymer (at the tested concentrations), which requires an additional
heating step to allow the polymer solution to be transferred via pipette. In addition,
further complications arise from the spheroid transfer process itself, as well as from the
limitations on spheroid location within the hydrogel, which is imposed by the opaque
nature of the composite hydrogels tested. Both of these problems could be potentially
reduced (or even removed entirely) by proper concentration optimization or possibly via
minor chemical alterations to the Polymer 2 itself.
Finally, further research could also be carried out to assess the viability of composite
hydrogels  as  a  subcutaneous  tumor  carrier  for  xenografts  in  animal  models.  While
Matrigel is typically used for tumor inoculation,  recent studies have shown, that for of
certain  types tumors,  such  as  ovarian tumors,  tumor  cells  inoculated from collagen
hydrogels show a higher degree of vascularization when compared to cells grown in
Matrigel, alginate or agarose [31]. Due to similar tumor cell growth rates displayed by
the Polymer 2c composite hydrogels, it is possible that a similar rate of in vivo may also
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be  achievable  using  composite  hydrogels,  greatly  increasing  the  cost  viability  and
accessibility of various tumor modeling studies.
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1.   Rheological Measurements









rad/s Pa Pa Pa.s
0.1 106501 341151 3573880
0.125893 113449 339634 2844340
0.158489 5964.05 -6688.42 56541.9
0.199526 102.533 5.73375 514.686
0.251189 110.084 5.33641 438.766
0.316228 103.36 19.9695 332.897
0.398107 107.081 18.4639 272.944
0.501187 124.107 20.5821 251.007
0.630957 98.6027 9.96859 157.071
0.794328 92.183 25.1872 120.305
1 106.131 24.6307 108.951
1.25893 119.818 18.3618 96.2863
1.58489 139.776 20.7696 89.1611
1.99526 123.421 12.5833 62.1779
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2.51189 130.096 7.15242 51.8706
3.16228 133.171 20.7448 42.6203
3.98107 130.318 4.07152 32.7504
5.01187 117.187 -27.0875 23.9985
6.30957 139.83 18.0905 22.3462
7.94328 137.877 -6.29901 17.3758
10 181.769 -110.921 21.294
12.5893 217.575 24.9309 17.3957
15.8489 159.036 21.992 10.13
19.9526 163.74 18.5369 8.25884
25.1189 164.602 26.9399 6.64012
31.6228 175.726 22.1419 5.60087
39.8107 174.835 16.5251 4.41123
50.1187 213.205 8.73748 4.25757
63.0957 238.033 -269.33 5.69676
79.4328 -119.064 -105.061 1.99904
100 -22.5616 1.90376 0.226417










rad/s Pa Pa Pa.s
0.1 228.811 -193.551 2996.94
0.125893 143.994 50.3842 1211.79
0.158489 141.01 57.6236 961.137
0.199526 383.758 225.238 2230.16
0.251189 150.36 39.3953 618.798
0.316228 164.122 54.8714 547.239
0.398107 1170.25 1032.42 3919.98
0.501187 859.902 -871.674 2443.07
0.630957 155.124 72.3093 271.254
0.794328 170.182 59.9619 227.156
1 216.115 57.6831 223.681
1.25893 145.962 50.3958 122.658
1.58489 151.095 55.4929 101.561
1.99526 160.473 26.4416 81.5115
2.51189 167.688 46.7621 69.3048
3.16228 196.412 25.9435 62.6505
3.98107 173.327 64.9133 46.4909
5.01187 71.5608 31.3781 15.5906
6.30957 182.077 52.7273 30.0429
7.94328 187.55 82.1057 25.7746
10 157.906 56.1162 16.7581
12.5893 212.638 55.0622 17.4475
15.8489 170.788 49.6811 11.2227
19.9526 178.052 52.2585 9.30014
25.1189 178.188 60.1511 7.48707
31.6228 183.135 55.6061 6.05231
39.8107 156.435 34.8398 4.02574
50.1187 174.617 35.5023 3.55535
63.0957 98.4744 -132.061 2.61085
79.4328 -189.706 -37.1904 2.43372
100 -46.1827 146.095 1.53221
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rad/s Pa Pa Pa.s
0.1 37.8601 35.7337 520.604
0.125893 72.6693 18.1151 594.898
0.158489 74.9378 28.4971 505.859
0.199526 61.8632 17.5927 322.344
0.251189 43.9178 39.3643 234.793
0.316228 92.754 35.9729 314.601
0.398107 74.1507 42.6598 214.883
0.501187 79.8299 28.2843 168.984
0.630957 96.0012 33.1767 160.981
0.794328 86.2601 23.2466 112.469
1 100.557 39.7036 108.112
1.25893 83.5494 20.0067 68.2419
1.58489 93.3482 23.7795 60.7797
1.99526 99.3203 38.3463 53.3593
2.51189 78.7892 57.9249 38.9312
3.16228 91.0904 12.4455 29.0729
3.98107 125.429 11.1959 31.6317
5.01187 153.522 -4.70185 30.646
6.30957 105.327 35.2765 17.6046
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7.94328 160.443 52.0256 21.2339
10 84.0698 77.159 11.4111
12.5893 182.67 0.694387 14.5101
15.8489 132.652 18.4224 8.45012
19.9526 127.311 -53.5019 6.92118
25.1189 135.024 41.9391 5.62874
31.6228 155.223 35.9187 5.03827
39.8107 145.892 29.7727 3.74017
50.1187 188.224 34.4829 3.81807
63.0957 296.898 -226.891 5.92224
79.4328 -145.207 -84.1534 2.11285
100 -51.999 16.8318 0.546554









rad/s Pa Pa Pa.s
0.1 96.9235 24.0085 998.528
0.125893 84.0308 56.9817 806.472
0.158489 97.1363 27.5191 637.01
0.199526 125.521 26.2615 642.714
0.251189 102.467 37.2578 434.059
0.316228 120.251 29.1595 391.286
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0.398107 122.808 11.2186 309.764
0.501187 137.835 29.6224 281.297
0.630957 129.882 28.5053 210.749
0.794328 124.95 43.5264 166.574
1 148.051 30.8295 151.227
1.25893 137.023 31.4634 111.674
1.58489 148.267 52.0737 99.1521
1.99526 154.219 37.8543 79.587
2.51189 142.928 24.2702 57.7151
3.16228 142.575 20.9013 45.5681
3.98107 143.05 22.3629 36.3689
5.01187 137.542 13.4625 27.5744
6.30957 155.62 34.6899 25.2694
7.94328 192.214 52.8842 25.0975
10 201.303 51.7336 20.7844
12.5893 155.609 -2.25665 12.3618
15.8489 180.732 40.1768 11.6818
19.9526 184.068 42.7357 9.47065
25.1189 183.961 40.646 7.50024
31.6228 203.301 47.9822 6.60558
39.8107 210.277 33.4885 5.34849
50.1187 230.106 31.1432 4.63308
63.0957 326.092 -167.271 5.80849
79.4328 -78.6263 -75.4145 1.37156
100 -12.4984 41.649 0.434839
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rad/s Pa Pa Pa.s
0.1 96.9235 24.0085 998.528
0.125893 84.0308 56.9817 806.472
0.158489 97.1363 27.5191 637.01
0.199526 125.521 26.2615 642.714
0.251189 102.467 37.2578 434.059
0.316228 120.251 29.1595 391.286
0.398107 122.808 11.2186 309.764
0.501187 137.835 29.6224 281.297
0.630957 129.882 28.5053 210.749
0.794328 124.95 43.5264 166.574
1 148.051 30.8295 151.227
1.25893 137.023 31.4634 111.674
1.58489 148.267 52.0737 99.1521
1.99526 154.219 37.8543 79.587
2.51189 142.928 24.2702 57.7151
3.16228 142.575 20.9013 45.5681
3.98107 143.05 22.3629 36.3689
5.01187 137.542 13.4625 27.5744
6.30957 155.62 34.6899 25.2694
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7.94328 192.214 52.8842 25.0975
10 201.303 51.7336 20.7844
12.5893 155.609 -2.25665 12.3618
15.8489 180.732 40.1768 11.6818
19.9526 184.068 42.7357 9.47065
25.1189 183.961 40.646 7.50024
31.6228 203.301 47.9822 6.60558
39.8107 210.277 33.4885 5.34849
50.1187 230.106 31.1432 4.63308
63.0957 326.092 -167.271 5.80849
79.4328 -78.6263 -75.4145 1.37156
100 -12.4984 41.649 0.434839









rad/s Pa Pa Pa.s
0.1 122.016 64.7819 1381.47
0.125893 151.343 34.6215 1233.21
0.158489 146.74 56.2436 991.544
0.199526 151.098 54.911 805.741
0.251189 177.269 45.7341 728.829
0.316228 166.992 26.0263 534.451
0.398107 204.36 52.3629 529.912
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0.501187 211.226 54.1369 435.074
0.630957 219.927 29.9303 351.774
0.794328 244.045 63.6763 317.52
1 234.468 52.0402 240.173
1.25893 246.114 76.7562 204.782
1.58489 258.113 43.9517 165.202
1.99526 257 36.7306 130.114
2.51189 254.691 53.9862 103.647
3.16228 260.79 37.8314 83.3321
3.98107 284.001 18.5172 71.4892
5.01187 314.681 2.01355 62.7884
6.30957 272.671 45.9016 43.8235
7.94328 258.463 42.1543 32.9685
10 257.87 22.773 25.8874
12.5893 284.691 78.4234 23.4561
15.8489 282.658 29.3403 17.9304
19.9526 300.781 38.6778 15.1989
25.1189 301.329 43.3004 12.1194
31.6228 320.894 42.8947 10.2378
39.8107 307.561 33.1233 7.77026
50.1187 371.774 48.0154 7.47947
63.0957 426.849 -151.652 7.17938
79.4328 41.6718 -88.0989 1.22692
100 114.859 16.5137 1.1604










rad/s Pa Pa Pa.s
0.1 232.712 220.169 3203.58
0.125893 240.793 206.375 2519.06
0.158489 169.506 -152.473 1438.53
0.199526 304.418 225.123 1897.58
0.251189 304.623 235.562 1533.02
0.316228 339.637 205.044 1254.58
0.398107 348.835 210.933 1023.97
0.501187 384.515 200.911 865.624
0.630957 374.699 193.447 668.332
0.794328 451.494 189.5 616.433
1 454.762 166.186 484.176
1.25893 419.995 171.522 360.362
1.58489 436.21 173.482 296.197
1.99526 402.769 154.716 216.243
2.51189 462.136 156.06 194.187
3.16228 442.42 136.08 146.374
3.98107 428.212 135.37 112.809
5.01187 415.066 140.164 87.4111
6.30957 490.273 130.836 80.4223
7.94328 492.625 113.155 63.6328
10 511.829 92.4637 52.0114
12.5893 479.963 71.6487 38.5473
15.8489 462.234 112.826 30.0212
19.9526 477.342 119.344 24.6602
25.1189 477.805 119.99 19.6124
31.6228 486.838 118.417 15.844
39.8107 465.033 110.097 12.004
50.1187 489.11 108.418 9.99591
63.0957 313.45 -146.01 5.48038
79.4328 428.257 216.063 6.03874
100 541.103 300.061 6.18732
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rad/s Pa Pa Pa.s
0.1 286.906 189.857 3440.36
0.125893 327.044 188.38 2997.94
0.158489 395.61 176.025 2732.07
0.199526 417.888 159.245 2241.32
0.251189 428.109 179.012 1847.33
0.316228 452.985 177.817 1538.88
0.398107 406.369 175.264 1111.64
0.501187 450.021 165.307 956.573
0.630957 483.23 177.032 815.645
0.794328 414.366 178.187 567.844
1 454.037 186.53 490.86
1.25893 547.227 210.013 465.589
1.58489 535.839 197.053 360.228
1.99526 553.185 198.04 294.48
2.51189 483.391 183.757 205.877
3.16228 657.136 210.031 218.161
3.98107 541.655 214.094 146.3
5.01187 634.925 248.223 136.021
6.30957 541.083 213.117 92.168
7.94328 549.79 99.4161 70.337
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10 658.491 173.885 68.1063
12.5893 528.154 243.454 46.1952
15.8489 610.89 239.012 41.3897
19.9526 630.534 245.441 33.9113
25.1189 656.429 252.205 27.9954
31.6228 678.135 260.255 22.9695
39.8107 760.298 203.92 19.7728
50.1187 536.398 231.842 11.6595
63.0957 598.981 274.253 10.441
79.4328 631.64 314.316 8.88202
100 683.518 361.646 7.73294
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2.   Spheroid Growth Data
2.1   Hydrogel encapsulated spheroid growth over seven days
2.5% Collagen
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
222.52 229.213 231.713 238.671 235.289 242.739 258.96
240.256 243.469 238.292 251.428 260.554 258.451 264.763
226.28 231.145 248.395 265.861 260.583 264.582 262.901
300.25 310.505 328.456 340.541 360.984 363.774 403.445
232.56 238.053 245.254 265.465 285.82 290.401 302.227
312.247 314.667 335.425 289.587 423.66 444.381 438.254
328.25 334.555 339.682 339.482 341.107 351.146 362.724
278.56 286.355 310.44 361.114    
244.56 246.865 268.481 300.015    
1.66% Collagen/1.6mg Polymer 2a
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
284 292 291 294 299 301 301
213 230 229 237 255 252 256
240 260 267 267 272 275 279
199 196 213 209 232 240 243
275 275 280 273 275 280 289
274 279 279 280    
171 175 167 168    
142 135      
225  247     
244  267     
68
246  252     
271  282     
184  193     
238  263     
1.66% Collagen/1.6mg Polymer 2b
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
263.691 274.905 258.235 276.358 273.821  289
298.31 300.746 306.725 301 312  335
194.349 199.532 208 212.441 218  228
215 239 234 235 240 248 275
242 266 252 260 268 272 289
213 238 234 219 226 229 240
253 278 269 264 268 272 284
186  199 202 206 211 219
147  180 164 165 168 183
165  186 192 199 224 222
1.66% Collagen/1.6mg Polymer 2c
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
314.556 338.457 368.525 391.908 401.584 408.148 416.992
110.856 118.692 112.554 127.425 139.541 152.05 150.241
272.586 275.992 277.55 281.555 285.541 290.08 289.945
265.578 273.544 285.547 297.494 312.544 356.53 363.364
205.547 225.456 235.78 246.786 254.544 265.08 279.558
256.855 254.743 251.922     
250.288 303.862 285.291     
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267.456 304.797 311.142     
278.007 313.497 344.98     
1.66% Collagen/1.6mg Polymer 2d
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
242.56 247.936 247.687 245.424 280.796 280.579 279.528
238.58 239.709 239.582 239.709 238.29 245.578 247.285
266.524 266.257 268.268 268.554 263.213 265.547 270.056
252.525 255.133 259.586 263.558 259.865 267.169 285.996
221.358 221.88 226.548 231.984 237.38 241.548 247.58
224.856 233.554 248.589 242.99 246.548 253.332 264.778
244.582    239.191 244.586 249.547
220.542   214.701 217.915 224.225 226.548
1.66% Collagen/3.3mg Polymer 2d
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
248.92 249.921 266.637 255.114 262.619 265.205 263.923
264.58 269.684 272.068 279.954 277.727 278.784 269.22
270.58 272.688 264.348 267.424 257.362 251.73 248.769
267.58 268.791 274.15 291.025 280.736 244.124 240.985
328.58 323.119 305.839 302.791 305.858 304.445 309.737
248.52 252.326 283.353 278.757 282.455 289.414 295.935
245.25 250.085 267.72 292.341 314.454 329.44 344.844
270.24 282.132 280.26 305.859    
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2.2   Spheroid growth after doxorubicin treatment (IC50)
1.66% Collagen/1.6 mg Polymer 2c
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
285.527 307.423 332.304 324.304 352.511 350 346.88
263.207 292.812 290.972 295.883 314.43 315.65 314.67
268.12 291.784 300.622 317.985 328.49 330.13 339.34
233.132 249.586 265.098 279.415 321.483 323.554 330.087
303.916 329.262 342.865 374.356 380.471 378.58 373.184
272.12 293.784 304.622 319.985 325.49 332.13 341.34
1.66% Collagen/1.3 mg Polymer 2c
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
292.106 300.706 316.757 323.448 335.055 341.638 344.969
242.523 238.127 234.604 227.79 230.18 231.341 228.979
291.659 295.873 301.528 305.291 301.741 312.317 313.59
256.115 284.828 287.405 297.991 305.737 318.899 323.563
317.257 326.425 329.47 330.176 330.645 330.648 341.241
282.012 288.345 290.946 338.635 353.914 361.665 368.021
293.751 291.878 310.672 319.839 322.189 321.502 330.71
308.098 315.136 322.677 325.24 339.107 336.99 341.706
285.774 276.838 284.825 322.656 338.636 340.758 346.159
317.25 310.905 323.174 354.154 358.386 354.154 355.559
313.971 325.711 331.117 331.585 337.461 348.741 354.635
289.05 299.641 305.974 326.181 329.705 329.47 329.24
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2.5% Collagen (DOX)
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
224.892 235.593 238.783 237.862 257.565 257.565 264.852
198.593 206.589 207.27 209.642 209.161 208.685 216.441
220.195 181.211 192.936 191.764 191.781 195.575 196.674
204.222 200.221 219.038 230.312 227.482 232.25 237.153
226.07 249.573 251.451 252.411 244.649 245.25 250.04
234.369 268.135 263.201 269.078 263.224 268.57 271.428
241.348 260.387 262.754 265.315 266.498 264.586 265.315
204.933 230.771 239.938 235.004 228.67 228.596 229.83
274.184 285.336 289.978 300.047 311.64 312.496 310.363
280.261 297.791 317.25 334.235 333.029 334.586 337.254
108.79 123.809 142.148 162.198 169.044 165.156 160.769
Non-gel Spheroids (DOX)
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
294.221 273.776 261.5 254.273 258.975 237.82 218.431
271.428 271.9 261.56 225.838 246.335 224.425 202.191
284.162 278.945 249.61 238.776 236.645 210.618 223.251
262.735 286.94 269.318 250.513 248.164 216.437 215.266
259.205 259.461 234.6 249.335 208.246 225.375 216.08
265.32 285.29 253.097 250.523 243.963 240.897 238.806
288.815 269.076 274.488 255.683 249.371 227.519  
269.31 303.388 261.331 254.27 264.848 247.703  
282.94 274.534 250.989 233.356 224.666 225.375  
272.366 255.488 251.688 255.933 241.345 243.704  
285.29 274.488 252.181 243.46 236.175 216.44
72
288.376 273.075 268.137 245.81 251.45 221.141  
1.66% Collagen/1.6mg Polymer 2a
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
284 292 291 294 299 301 301
213 230 229 237 255 252 256
240 260 267 267 272 275 279
199 196 213 209 232 240 243
275 275 280 273 275 280 289
274 279 279 280 285 289 290
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